The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

FDA approves Zepbound for obstructive sleep apnea in obese individuals Discover how this weight-loss drug reduces symptoms ...

( NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

GLP-1 drugs are driving down grocery spending, according to a new study from Cornell’s SC Johnson College of Business and ...

The U.S. Food and Drug Administration (FDA) has approved Zepbound, a prescription weight-loss medication, as the first drug ...

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...

Sleep apnea causes people to stop and start breathing repeatedly Zepbound is first drug approved ... the FDA said. In addition, those who took Zepbound saw their body weight decrease significantly ...

(NewsNation) — Zepbound became the first drug approved by the ... of apnea or hypopnea,” the FDA said. In addition, those who took Zepbound saw their body weight decrease significantly ...